Ind-Swift Limited (INDSWFTLTD)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
9.95
-0.5(-4.78%)

Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.

Pricing Updates

TODAY'S HIGH

10.85

TODAY'S LOW

9.95

52 WEEK HIGH

18.5

52 WEEK LOW

4.6

Major Holders

% of Shares Held by
All Insider

66.46%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

53.89 Cr.

ETERPRISE VALUE

1037.47 Cr.

NO. OF SHARES

5.41 Cr.

BOOK VALUE

-129.754

DIV. YIELD

0.4%

DEBT

996.72 Cr.

GROSS PROFIT

170.93 Cr.

CASH

19.06 Cr.

REVENUE

389.76 Cr.

REVENUE/SHARE

71.849

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments1.60 Cr.1.60 Cr.1.60 Cr.-3.69 Cr.
Change To Liabilities0000
Total cashflows from Investing Activities-16.71 Cr.-11.35 Cr.-13.70 Cr.-6.42 Cr.
Net Borrowings-4.67 Lakhs5.94 Cr.-9.78 Cr.-7.25 Cr.
Total Cash from Financing Activities-48.29 Cr.-26.20 Cr.-13.03 Cr.-6.17 Cr.
Other Liabilities50.04 Cr.25.20 Cr.16.94 Cr.1.89 Cr.
Total Assets0000
Net Income-29.81 Cr.-19.12 Cr.8.19 Cr.-50.42 Cr.
Change in Cash12.23 Cr.-2.96 Cr.16.04 Cr.-5.42 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities77.24 Cr.34.59 Cr.42.78 Cr.7.16 Cr.
Depreciation30.70 Cr.33.59 Cr.33.97 Cr.32.64 Cr.
Other Cashflows from Investing Activities1.81 Cr.1.01 Cr.28.48 Lakhs13.53 Lakhs
Dividends Paid0000
Change to Inventory-10.44 Cr.-3.40 Cr.-3.55 Cr.-6.37 Cr.
Change to Account Receivables-15.91 Cr.-20.76 Cr.-10.98 Lakhs-11.79 Cr.
Other Cashflows from Financing Activities-48.25 Cr.-32.14 Cr.-3.25 Cr.1.08 Cr.
Change to Net Income50.67 Cr.19.09 Cr.-12.65 Cr.39.24 Cr.
Capital Expenditures-20.21 Cr.-12.63 Cr.-14.02 Cr.-6.15 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-29.49 Cr.-16.66 Cr.8.19 Cr.-49.67 Cr.
Minority InterestNoneNoneNoneNone
Net Income14.25 Cr.2.77 Cr.-16.57 Cr.-16.55 Cr.
Selling General Administrative60.44 Cr.56.46 Cr.54.23 Cr.50.12 Cr.
Gross Profit170.93 Cr.146.31 Cr.131.21 Cr.111.89 Cr.
Ebit14.25 Cr.2.77 Cr.-16.57 Cr.-16.55 Cr.
Operating Income14.25 Cr.2.77 Cr.-16.57 Cr.-16.55 Cr.
Other Operating Expenses63.52 Cr.53.48 Cr.59.57 Cr.43.69 Cr.
Interest Expense-51.45 Cr.-34.66 Cr.-3.47 Cr.-11.12 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense32.28 Lakhs2.46 Cr.075.06 Lakhs
Total Revenue359.66 Cr.336.87 Cr.295.16 Cr.273.30 Cr.
Total Operating Expenses345.40 Cr.334.09 Cr.311.73 Cr.289.85 Cr.
Cost of Revenue188.73 Cr.190.55 Cr.163.95 Cr.161.41 Cr.
Total Other Income Expense Net-43.75 Cr.-19.43 Cr.24.76 Cr.-33.12 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-29.81 Cr.-19.12 Cr.8.19 Cr.-50.42 Cr.
Net Income Applicable to Common Shares-29.81 Cr.-19.12 Cr.8.19 Cr.-50.42 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets11.93 Cr.16.07 Cr.20.07 Cr.23.99 Cr.
Capital Surplus71.07 Cr.71.07 Cr.71.07 Cr.71.07 Cr.
Total Liabilities1366.73 Cr.1314.76 Cr.1275.16 Cr.1277.93 Cr.
Stock Holder Equity-695.16 Cr.-713.11 Cr.-676.73 Cr.-677.38 Cr.
Minority Interest0000
Other Liabilities82.34 Cr.41.16 Cr.40.13 Cr.48.72 Cr.
Total Assets671.57 Cr.601.64 Cr.598.42 Cr.614.75 Cr.
Common Stock10.83 Cr.10.83 Cr.10.83 Cr.10.83 Cr.
Retained Earnings-807.66 Cr.-777.85 Cr.-758.73 Cr.-761.79 Cr.
Other Liabilities16.21 Cr.16.24 Cr.14.62 Cr.12.69 Cr.
Good Will0000
Treasury Stock30.59 Cr.-17.17 Cr.8.18 Lakhs2.50 Cr.
Other Assets147.46 Cr.99.88 Cr.110.42 Cr.114.10 Cr.
Cash28.99 Cr.16.75 Cr.19.72 Cr.3.67 Cr.
Current Liabilities706.16 Cr.654.12 Cr.615.86 Cr.598.24 Cr.
Long Term Asset Charges0000
Short Long Term Debt2.51 Cr.2.02 Cr.1.34 Cr.8.77 Lakhs
Other Stockholder Equity30.59 Cr.-17.17 Cr.8.18 Lakhs2.50 Cr.
Property Plant Equipment245.13 Cr.253.59 Cr.270.48 Cr.286.68 Cr.
Total Cur. Assets265.17 Cr.228.64 Cr.193.51 Cr.186.10 Cr.
Long Term Investments1.86 Cr.3.44 Cr.3.92 Cr.3.85 Cr.
Net Tangible Assets-707.10 Cr.-729.18 Cr.-696.80 Cr.-701.37 Cr.
Short Term Investments0000
Net Receivables107.94 Cr.94.16 Cr.75.56 Cr.83.50 Cr.
Long Term Debt644.16 Cr.644.21 Cr.644.67 Cr.666.99 Cr.
Inventory62.84 Cr.52.40 Cr.48.99 Cr.45.43 Cr.
Accounts Payable232.01 Cr.226.22 Cr.198.83 Cr.166.30 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account